SEC Filing Analysis: NATIONAL RESEARCH CORP (NRC)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director was granted stock options for 22,625 shares as compensation for board service, a routine event with minor potential shareholder dilution.
• Market Impact: Neutral. This is a standard form of non-cash compensation and not an indicator of a change in insider sentiment based on market conditions.

Company Information

Field	Value
Company	NATIONAL RESEARCH CORP
Ticker Symbol	NRC
CIK	0000070487
Industry	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

Insider Information

Field	Value
Name	NUNNELLY JOHN N
CIK	0001248110
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-17
Transaction Code	A (Grant)
Security Type	Director Stock Option (Right to Buy)
Shares Involved	22,625
Price Per Share	$0.00
Total Value	$0
Shares Owned After	22,625 (Derivative securities)
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.0%
Shares Transacted (Underlying)	22,625
% of Shares Outstanding	0.098%
Post-Transaction Ownership	22,625 options (underlying shares not specified)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a market capitalization of $280 million, a $0 value transaction has no immediate financial impact. The significance lies in the potential future dilution.
• Ownership Concentration: The filing indicates the director now holds options to acquire 22,625 shares. Without information on prior non-derivative holdings, the total ownership concentration cannot be fully assessed, but this grant establishes a new derivative position.
• Dilution Impact: The grant of options to purchase 22,625 shares represents a potential future dilution of approximately 0.098% of the total shares outstanding. This is a minor level of dilution for existing shareholders.
• Transaction Significance: The transaction is rated as 'Low' significance. The value is $0, and the number of underlying shares represents less than 0.1% of the company's outstanding shares. As a grant for services, it does not signal insider confidence in the same way an open-market purchase would.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Equity grants to directors are a common form of compensation and are typically priced into the stock as part of general and administrative expenses. This event is unlikely to move the stock price.

Volume & Sentiment

• Expected Volume Impact: Minimal. The transaction did not occur on the open market and does not create immediate trading activity.
• Sentiment Indicator: Neutral. This is a routine corporate governance action, not a bullish or bearish market signal.

Investment Insights

Positive Market Indicators

• Aligning director interests with shareholders through equity compensation is generally seen as a positive governance practice.

Risk Factors

• While minor in this case, ongoing equity grants contribute to shareholder dilution over time.

Key Takeaways

1. Compensation, Not Conviction: This is a grant for board service, not an insider using personal funds to increase their stake.
2. Minor Dilution: The potential dilution from these options is less than 0.1%, which is not material to current shareholders.
3. Routine Action: The grant was made under the company's pre-approved 2025 Omnibus Incentive Plan, indicating it is a standard, planned corporate action.

Additional Context

Transaction Notes

• Special Circumstances: The filing footnote specifies the award was granted for participation in two in-person meetings during 2025.
• Option Terms: The options have an exercise price of $11.61 and expire in ten years, on October 17, 2035.